Gene · 54681
Papers302
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 302
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Potential Therapeutic Targets and Drugs for Depression: A Genome-Wide Druggable Mendelian Randomization and Molecular Docking Study. | Curr Med Chem | 2026 | 42576535 | PubTator, text mining | PubMed |
| ChSCL9 negatively regulates citric acid accumulation via repressing PH4-PH5 module in kumquat. | Plant Physiol | 2026 | 42378656 | PubTator, text mining | PubMed |
| Convergent molecular signatures across eating disorders and obsessive-compulsive disorder in the human brain. | Cell Rep | 2026 | 42295976 | PubTator, text mining | PubMed |
| Research advances in biosynthesis of trans-4-hydroxy-L-proline. | J Biotechnol | 2026 | 41911954 | PubTator, text mining | PubMed |
| Molecular determinants of allosteric modulation of protein disulfide isomerase by small-molecule b'-ligands. | Redox Biol | 2026 | 41610518 | PubTator, text mining | PubMed |
| Vibrational spectra of the radiation-induced cationic species resulting from phosphine monomers and dimers: A matrix isolation and CCSD(T) study. | J Chem Phys | 2026 | 41492990 | PubTator, text mining | PubMed |
| Advances in the genetics of refractive errors: Contributions from the CREAM consortium. | Acta Ophthalmol | 2026 | 41230783 | PubTator, text mining | PubMed |
| In Silico Optimization of Inhibitors of the 3-Chymotrypsin-like Protease of SARS-CoV-2. | Life (Basel) | 2025 | 41598161 | PubTator, text mining | PubMed |
| Exploration into the MLL4/WRAD Enzyme-Substrate Network: Systematic In Vitro Identification of CFP1 as a Potential Non-Histone Substrate of the MLL4 Lysine Methyltransferase. | Epigenomes | 2025 | 41133716 | PubTator, text mining | PubMed |
| Integrated Approach of Machine Learning and High-Throughput Screening to Identify Chemical Probe Candidates Targeting Aldehyde Dehydrogenases. | ACS Pharmacol Transl Sci | 2025 | 41098570 | PubTator, text mining | PubMed |
| Exploration of potential novel drug targets for rheumatoid arthritis by plasma proteome screening. | PLoS Comput Biol | 2025 | 40996951 | PubTator, text mining | PubMed |
| Identification of potential therapeutic targets for problematic alcohol use using multi-omics data. | EBioMedicine | 2025 | 40966854 | PubTator, text mining | PubMed |
| From laboratory to clinic: opportunities and challenges of functional food active ingredients in cancer therapy. | Front Nutr | 2025 | 40808836 | PubTator, text mining | PubMed |
| Association of Helicobacter pylori with Serum HIF-1α, HIF-2α, and Human Transmembrane Prolyl 4-Hydroxylase Activity in Patients with Chronic Gastritis. | Medicina (Kaunas) | 2025 | 40731804 | PubTator, text mining | PubMed |
| A Novel Formula Based Model for Predicting Skeletal Maturation in Maharashtra. | J Pharm Bioallied Sci | 2025 | 40510996 | PubTator, text mining | PubMed |
| Integrative multi-omics investigation of sleep apnea: gut microbiome metabolomics, proteomics and phenome-wide association study. | Nutr Metab (Lond) | 2025 | 40495162 | PubTator, text mining | PubMed |
| Novel compound heterozygous P4HTM variants in a girl with developmental and epileptic encephalopathy: First case report of P4HTM variant-associated epileptic encephalopathy. | Seizure | 2025 | 39612909 | PubTator, text mining | PubMed |
| Navigating Complexity: Spiritual Care Discourses Among Swedish Palliative Care Professionals. | J Relig Health | 2025 | 39162774 | PubTator, text mining | PubMed |
| Clinical characteristics of patients with P4HTM variant-associated epilepsy and therapeutic exploration: a case report and literature review. | Front Neurol | 2024 | 39582684 | PubTator, text mining | PubMed |
| Serum metabonomics reveal the effectiveness of human placental mesenchymal stem cell therapy for primary sclerosing cholangitis. | Stem Cell Res Ther | 2024 | 39380092 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54681/papers